Abstract:Abstract Background Cisplatin is widely used for chemotherapy of head and neck squamous cell carcinoma. However, details of the molecular mechanism responsible for cisplatin resistance are still unclear. The aim of this study was to identify the expression of genes related to cisplatin resistance in oral squamous cell carcinoma cells. Methods A cisplatin-resistant cell line, Tca/cisplatin, was established from a cisplatin-sensitive cell line, Tca8113, which was derived from moderately-differentiated tongue squamous cell carcinoma. Global gene expression in this resistant cell line and its sensitive parent cell line was analyzed using Affymetrix HG-U95Av2 microarrays. Candidate genes involved in DNA repair, the MAP pathway and cell cycle regulation were chosen to validate the microarray analysis results. Cell cycle distribution and apoptosis following cisplatin exposure were also investigated. Results Cisplatin resistance in Tca/cisplatin cells was stable for two years in cisplatin-free culture medium. The IC50 for cisplatin in Tca/cisplatin was 6.5-fold higher than that in Tca8113. Microarray analysis identified 38 genes that were up-regulated and 25 that were down-regulated in this cell line. Some were novel candidates, while others are involved in well-characterized mechanisms that could be relevant to cisplatin resistance, such as RECQL for DNA repair and MAP2K6 in the MAP pathway; all the genes were further validated by Real-time PCR. The cell cycle-regulated genes CCND1 and CCND3 were involved in cisplatin resistance; 24-hour exposure to 10 μM cisplatin induced a marked S phase block in Tca/cisplatin cells but not in Tca8113 cells. Conclusion The Tca8113 cell line and its stable drug-resistant variant Tca/cisplatin provided a useful model for identifying candidate genes responsible for the mechanism of cisplatin resistance in oral squamous cell carcinoma. Our data provide a useful basis for screening candidate targets for early diagnosis and further intervention in cisplatin resistance.

Establishment and Biological Characteristics of Cisplatin-Resistant Cell Line from Human Tongue Squamous Cell Carcinoma Tca8113

[Establishment and Drug-Resistance Gene Expression of Cisplatin-Resistant Cell Line Tca8113/CDDP].

Xct Expression Modulates Cisplatin Resistance in Tca8113 Tongue Carcinoma Cells.

Establishment of a cisplatin-induced human esophageal carcinoma drug-resistant cell line and its biological characteristics

Identification of Genes Associated with Cisplatin Resistance in Human Oral Squamous Cell Carcinoma Cell Line

Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line

Chemosensitivity of Tca8113 and BcaCD885 Cell Lines to Cisplatin Loaded Polylactic Acid-polyethylene Glycol Nanoparticles for Targeting Oral Carcinoma.

Establishment of Cisplatin-Resistant Human Bladder Cancer Cell Line and Investigation of Its Resistant Mechanism

Establishment of Cisplatin-Resistant Human Endometrial Cancer Cell Line and the Study of Its Resistant Mechanisms

[In Vitro Gene Silencing by Sirna of Cyclin D1 on Tongue Squamous Cell Carcinoma Cell Line Resistant to Cisplatin].

[Apoptosis of Tca8113 Cells Induced by Cisplatin and Their Cell Cycle Specificity].

Establishment of a Multidrug-resistance Cell Lines A549/CDDP from Human Lung Adenocarecinoma Cells

[Inhibition Effect on Tca8113/CDDP by Antisense Oligonucleotides of Cyclin D1 Combined with Cis Diamminedichloroplatinum].

Effects of PDTC on proliferation and apoptosis of Tca8113 cells

Plumbagin Has an Inhibitory Effect on the Growth of TSCC PDX Model and It Enhances the Anticancer Efficacy of Cisplatin.

Establishment and Characterization of a Docetaxel-Resistant Human Prostate Cancer Cell Line.

Establishment of a human large cell lung cancer multi-drug resistance cell line H460/cDDP and its biological characteristics

Cisplatin Induces Drug Resistance in Human Esophageal Squamous Carcinoma Cell Line EC109 by Decreasing CTR1 Protein Expression

Establishment and Characterization of Cisplatin-Resistant Cell Lines from Canine Mammary Gland Tumors.

Cisplatin induces drug resistance in human esophageal squamous carcinoma cells by reducing CTR1 expression

Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line.